389 related articles for article (PubMed ID: 18812547)
1. Menopausal hormone therapy in BRCA1 mutation carriers: uncertainty and caution.
Chlebowski RT; Prentice RL
J Natl Cancer Inst; 2008 Oct; 100(19):1341-3. PubMed ID: 18812547
[No Abstract] [Full Text] [Related]
2. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Breast Cancer Res Treat; 2010 Apr; 120(3):727-36. PubMed ID: 19672706
[TBL] [Abstract][Full Text] [Related]
4. Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
Eisen A; Lubinski J; Gronwald J; Moller P; Lynch HT; Klijn J; Kim-Sing C; Neuhausen SL; Gilbert L; Ghadirian P; Manoukian S; Rennert G; Friedman E; Isaacs C; Rosen E; Rosen B; Daly M; Sun P; Narod SA;
J Natl Cancer Inst; 2008 Oct; 100(19):1361-7. PubMed ID: 18812548
[TBL] [Abstract][Full Text] [Related]
5. Re: Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
Eisinger F; Huiart L
J Natl Cancer Inst; 2009 Feb; 101(4):277; author reply 277-8. PubMed ID: 19211447
[No Abstract] [Full Text] [Related]
6. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
von Schoultz B
Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
[No Abstract] [Full Text] [Related]
7. Postmenopausal hormone therapy and breast cancer.
Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
[TBL] [Abstract][Full Text] [Related]
8. Timing of hormone therapy influences breast cancer risk.
Harv Womens Health Watch; 2011 Apr; 18(8):7. PubMed ID: 21544975
[No Abstract] [Full Text] [Related]
9. Estrogen-progestin increases breast cancer risk.
Stephens MB
J Fam Pract; 2000 Apr; 49(4):301-2. PubMed ID: 10778832
[No Abstract] [Full Text] [Related]
10. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
Kuller LH
J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556
[No Abstract] [Full Text] [Related]
11. Do risks of hormone therapy persist after discontinuation?
J Fam Pract; 2008 Jun; 57(6):366, 369. PubMed ID: 18677802
[No Abstract] [Full Text] [Related]
12. Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought.
Speroff L
Menopause; 2008; 15(2):393-400. PubMed ID: 17925662
[TBL] [Abstract][Full Text] [Related]
13. Oestrogens and progestins and breast cancer risk in post-menopausal women.
La Vecchia C
Pharmacol Res; 1995 Dec; 32(6):323-4. PubMed ID: 8736479
[No Abstract] [Full Text] [Related]
14. Breast cancer: the role of hormone therapy.
Creasman WT
Semin Reprod Med; 2005 May; 23(2):167-71. PubMed ID: 15852202
[TBL] [Abstract][Full Text] [Related]
15. [Hormone replacement therapy in postmenopausal women and breast cancer risk: impact of estrogens deprivation and timing hypothesis].
Brettes JP; Mathelin C
Gynecol Obstet Fertil; 2007 Nov; 35(11):1092-4. PubMed ID: 17996474
[No Abstract] [Full Text] [Related]
16. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.
Lee E; Ma H; McKean-Cowdin R; Van Den Berg D; Bernstein L; Henderson BE; Ursin G
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk.
Rebbeck TR; Troxel AB; Shatalova EG; Blanchard R; Norman S; Bunin G; Demichele A; Schinnar R; Berlin JA; Strom BL
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1318-20. PubMed ID: 17548708
[No Abstract] [Full Text] [Related]
18. Landmark hormone replacement therapy study stopped after finding more harms than benefits.
Rollins G
Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323
[No Abstract] [Full Text] [Related]
19. Is combined estrogen/progestogen hormone therapy worth the risk?
Sturdee DW; MacLennan AH
Climacteric; 2003 Sep; 6(3):177-9. PubMed ID: 14567764
[No Abstract] [Full Text] [Related]
20. [Did the decrease in use of menopausal hormone therapy induce a decrease in the incidence of breast cancer in France (and elsewhere)?].
Ringa V; Fournier A
Rev Epidemiol Sante Publique; 2008 Oct; 56(5):297-301. PubMed ID: 18947946
[No Abstract] [Full Text] [Related]
[Next] [New Search]